ADIL: Adial Pharmaceuticals Inc filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

Historical context for ADIL

Across the 8 sessions after earlier ADIL headlines, the stock closed higher 3 times and lower 5 times, with a median move of 4.8% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

Keep researching ADIL

• What is Form 8-K?The SEC "current report" a public company files to disclose material events, generally within four business days of the event.
• Form 8-K explainedWhat a Form 8-K is, when it is due, and what each key item number means, from 1.01 material agreements and 2.02 earnings to 4.02 restatements and 5.02 executive changes.
• ADIL insider tradesEvery buy and sale reported by Adial Pharmaceuticals Inc officers, directors and large holders.
• ADIL financial statementsRevenue, profit, cash flow and balance sheet from Adial Pharmaceuticals Inc's SEC filings.